昆药集团：目前公司经营情况正常

Group 1 - The core viewpoint of the article is that Kunming Pharmaceutical Group is currently operating normally and is focused on enhancing its intrinsic value despite stock price fluctuations influenced by macroeconomic factors, industry cycles, and market sentiment [1] - The company management emphasizes the importance of addressing investor concerns and is committed to the strategic goal of becoming a leader in the "silver-haired health industry" [1] - The company is working on deepening business integration and strengthening operational management to continuously enhance its core competitiveness and long-term investment value [1]